{
    "root": "34636dcf-cc6f-1c47-e063-6394a90a728d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Aripiprazole",
    "value": "20250505",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        }
    ],
    "indications": "Aripiprazole Oral Tablets, are indicated for the treatment of:\n                  \n                  \n                     Schizophrenia\n  \n    \n                     \n                     Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder\n  \n    \n                     \n                     Adjunctive Treatment of Major Depressive Disorder\n  \n    \n                     \n                     Irritability Associated with Autistic Disorder\n  \n     \n                     \n                     Treatment of Tourette’s Disorder",
    "contraindications": "Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy ( 2.2 ) 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate ( 2.2 ) 10 to 15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients: monotherapy or as an adjunct to lithium or valproate ( 2.2 ) 2 mg/day 10 mg/day 30 mg/day Major Depressive Disorder – adults: adjunct  to antidepressants ( 2.3 ) 2 to 5 mg/day 5 to 10 mg/day 15 mg/day Irritability associated with autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette’s disorder – ( 2.5 ) Patients < 50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥ 50 kg 2 mg/day 10 mg/day 20 mg/day • Oral formulations: Administer once daily without regard to meals ( 2 ) • Known CYP2D6 poor metabolizers: Half of the usual dose ( 2.7 )",
    "warningsAndPrecautions": "Aripiprazole Tablets, USP have markings on one side and are available in\n                  5 mg, blue modified rectangle, “ARI”and “5”\n                  NDC: 70518-2897-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Aripiprazole Tablets is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis\n \n  [see Adverse Reactions (\n  \n   6.2)]."
}